Detalles de la búsqueda
1.
Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
Breast Cancer Res
; 18(1): 73, 2016 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27368476
2.
Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer.
Oncol Lett
; 17(2): 2177-2186, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30675282
3.
Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer.
Breast Cancer
; 24(3): 473-482, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27628678
4.
Plasma tenofovir trough concentrations are associated with renal dysfunction in Japanese patients with HIV infection: a retrospective cohort study.
J Pharm Health Care Sci
; 2: 22, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27688900
5.
Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.
Breast Cancer
; 23(6): 830-843, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26467036
6.
Erratum to: Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer.
Breast Cancer
; 24(4): 642, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28378258
Resultados
1 -
6
de 6
1
Próxima >
>>